A study to evaluate the safety and tolerability of the combination of an antidepressive therapy with oral fingolimod in the treatment of relapsing remitting multiple sclerosis patients with mild to moderate depression A study to evaluate the safety and tolerability of the combination of an antidepressive therapy with ...
A 21-week, multicenter, open label study to evaluate the safety and tolerability profile of the combination of a SSRI or SNRI antidepressive therapy with oral fingolimod in the treatment of RRMS patients with mild to moderate depression A 21-week, multicenter, open label study to evaluate the safety and tolerability profile of the comb ...